Caffeine intake enhances peak oxygen uptake and performance during high-intensity cycling exercise in moderate hypoxia.
Eur J Appl Physiol
; 124(2): 537-549, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-37608124
ABSTRACT
PURPOSE:
We investigated whether caffeine consumption can enhance peak oxygen uptake ([Formula see text]) by increasing peak ventilation during an incremental cycling test, and subsequently enhance time to exhaustion (TTE) during high-intensity cycling exercise in moderate normobaric hypoxia.METHODS:
We conducted a double-blind, placebo cross-over design study. Sixteen recreational male endurance athletes (age 20 ± 2 years, [Formula see text] 55.6 ± 3.6 ml/kg/min, peak power output 318 ± 40 W) underwent an incremental cycling test and a TTE test at 80% [Formula see text] (derived from the placebo trial) in moderate normobaric hypoxia (fraction of inspired O2 15.3 ± 0.2% corresponding to a simulated altitude of ~ 2500 m) after consuming either a moderate dose of caffeine (6 mg/kg) or a placebo.RESULTS:
Caffeine consumption resulted in a higher peak ventilation [159 ± 21 vs. 150 ± 26 L/min; P < 0.05; effect size (ES) = 0.31]. [Formula see text] (3.58 ± 0.44 vs. 3.47 ± 0.47 L/min; P < 0.01; ES = 0.44) and peak power output (308 ± 44 vs. 302 ± 44 W; P = 0.02, ES = 0.14) were higher following caffeine consumption than during the placebo trial. During the TTE test, caffeine consumption enhanced minute ventilation (P = 0.02; ES = 0.28) and extended the TTE (426 ± 74 vs. 358 ± 75 s; P < 0.01, ES = 0.91) compared to the placebo trial. There was a positive correlation between the percent increase of [Formula see text] following caffeine consumption and the percent increase in TTE (r = 0.49, P < 0.05).CONCLUSION:
Moderate caffeine consumption stimulates breathing and aerobic metabolism, resulting in improved performance during incremental and high-intensity endurance exercises in moderate normobaric hypoxia.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Resistência Física
/
Cafeína
Tipo de estudo:
Clinical_trials
Limite:
Adolescent
/
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article